XAC

• CAT Number: I011393
• CAS Number: 96865-92-8
• Molecular Formula: C21H28N6O4
• Molecular Weight: 428.49
• Purity: ≥95%
• Synonyms: (Z)-N-(2-aminoethyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy)acetimidic acid
• Target: Adenosine Receptor
• Solubility: Limited solubility
• Storage: Desiccate at RT
• IUPAC Name: N-(2-aminoethyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide
• InChI: InChI=1S/C21H28N6O4/c1-3-11-26-19-17(20(29)27(12-4-2)21(26)30)24-18(25-19)14-5-7-15(8-6-14)31-13-16(28)23-10-9-22/h5-8H,3-4,9-13,22H2,1-2H3,(H,23,28)(H,24,25)
• InChIKey: FIQGIOAELHTLHM-UHFFFAOYSA-N
• SMILES: CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)OCC(=O)NCCN

XAC(CAT: I011393) (8-(4-[((2-Aminoethyl)amino)carbonyl]methyloxy)phenyl)-1,3-dipropylxanthine) is a potent and selective adenosine receptor antagonist, widely used in pharmacological research. It exhibits high affinity for A1 and A2 adenosine receptors, making it a valuable tool for studying adenosine-mediated signaling pathways. By blocking adenosine receptors, XAC helps explore their roles in cardiovascular function, neuroprotection, and inflammatory responses. Its specificity and potency enable detailed investigations into adenosine receptor mechanisms, contributing to the development of therapies for conditions such as ischemia, chronic pain, and neurodegenerative diseases. XAC is suitable for both in vitro and in vivo studies, providing a robust tool for receptor-targeted research.